There are multiple studies showing a strong correlation between increased COX2 expression and carcinogenesis both in murine cancer models [10-13], as well as in human solid tumors and premalignant lesions of colon, lung, gastric, breast, squamous cell carcinoma of head and neck, esophageal and prostate[3-9]. This evidence concerns the gene PTGS2 and cancer.